XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Changes in Shareholders’ (Deficit) Equity - USD ($)
Class A
Ordinary Shares
Class B
Ordinary Shares
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 863 $ 24,137 $ (5,494) $ 19,506
Balance (in Shares) at Dec. 31, 2020 8,625,000      
Sale of 34,500,000 Units on March 2, 2021 through public offering $ 3,450 $ 3,450
Sale of 34,500,000 Units on March 2, 2021 through public offering (in Shares) 34,500,000     34,500,000
Excess of the fair value of private placement warrants over cash received 1,880,000 $ 1,880,000
Class A ordinary shares subject to possible redemption $ (3,450) (3,450)
Class A ordinary shares subject to possible redemption (in Shares) (34,500,000)      
Remeasurement of Class A ordinary shares subject to possible redemption     (1,904,137) (27,046,507) (28,950,644)
Net income 5,128,650 5,128,650
Balance at Dec. 31, 2021 $ 863 (21,923,351) (21,922,488)
Balance (in Shares) at Dec. 31, 2021 8,625,000      
Balance at Dec. 31, 2021 $ 863 (21,923,351) (21,922,488)
Balance (in Shares) at Dec. 31, 2021 8,625,000      
Balance at Dec. 31, 2021 $ 863 (21,923,351) (21,922,488)
Balance (in Shares) at Dec. 31, 2021 8,625,000      
Proceeds received on convertible note less than fair value 592,600 592,600
Accretion portion net against additional paid-in-capital (592,600) (592,600)
Accretion of Class A ordinary shares subject to possible redemption (2,727,125) (1,607,588) (4,334,713)
Reduction of deferred underwriting fee payable 8,784,563 8,784,563
Net income 5,982,340 5,982,340
Balance at Dec. 31, 2022 $ 863 $ 6,057,438 $ (17,548,599) $ (11,490,298)
Balance (in Shares) at Dec. 31, 2022 8,625,000